PURE Bioscience (PURE) to Present at the Aegis Healthcare Conference on September 28  
9/20/2012 10:14:27 AM

SAN DIEGO--(BUSINESS WIRE)--PURE Bioscience, Inc. (NASDAQ: PURE), the creator of the patented silver dihydrogen citrate (SDC) antimicrobial, announced that Chief Executive Officer Michael L. Krall is schedule to present at the Aegis Capital Healthcare Conference on Friday, September 28, 2012 at 8:00 a.m. Pacific. The conference is being held at The Wynn in Las Vegas.